| Pharmaceutical active ingredients: |
| Tolbutamide Sodium |
| Available forms, composition and doses of Orinase Diagnostic: |
| Injectable; Injection; Tolbutamide Sodium 1 g |
| Orinase Diagnostic medical category: |
| Human:Antidiabetic agents (type II diabetes)Potassium channel blockers first generationSulfonylurea group drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BB03 - TolbutamideV04CA01 - Tolbutamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Toluina | Tolbutamide | Unidentified Pharmaceutical Company |
| Tolumid | Tolbutamide | Unidentified Pharmaceutical Company |
| Toluvan | Tolbutamide | Unidentified Pharmaceutical Company |
| Tydadex | Tolbutamide | Lennon, South Africa; Aspen Pharmacare |
| Willbutamide | Tolbutamide | Unidentified Pharmaceutical Company |
| Rastinon | Tolbutamide; Tolbutamide Sodium | Sanofi-Aventis; Aspen Pharmacare |
| Tasmar | Tolcapone | Valeant Pharmaceuticals; ICN Pharmaceuticals; Inovail Healthcare Philippines; Meda; Pacific Pharmaceuticals; Roche; Zuellig Pharma |
| Fungifos | Tolciclate | Combustin Pharmazeutische Praparate |
| Kilmicen | Tolciclate | Pfizer |
| Kilmicene | Tolciclate | Pfizer |